Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 8.70% | -48.27% | -0.86% | ||
| Total Depreciation and Amortization | 1.92% | -1.99% | 20.80% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.40% | 1,594.39% | 4.90% | ||
| Change in Net Operating Assets | 88.27% | 522.21% | -161.19% | ||
| Cash from Operations | 40.03% | 39.10% | -51.41% | ||
| Capital Expenditure | -20.00% | -11.11% | 72.73% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -100.11% | -11.11% | 72.73% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | 0.00% | 11.11% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -100.15% | -- | -- | ||
| Cash from Financing | -100.07% | 58,580.00% | 0.00% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -113.72% | 94.21% | -50.90% | ||